Through multiple regulatory mechanisms, Pin1 promotes tumor initiation, development, and drug resistance by acting as an activator of some oncogenes and growth enhancers, or as an inactivator of some tumor suppressors and growth inhibitors (Yeh and Means, 2007; Lu and Hunter, 2014; Zhou and Lu, 2016). The gene discussed is PIN1; the disease is neoplasm.